Changzhou Qianhong Biopharma Co Ltd (002550) — Cash Flow Reinvestment Rate
Changzhou Qianhong Biopharma Co Ltd (002550) has a Cash Flow Reinvestment Rate of 0.10x as of September 2025, reinvesting CN¥15.58 Million (capex CN¥15.58 Million ) from operating cash flow of CN¥156.34 Million. See 002550 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Changzhou Qianhong Biopharma Co Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Changzhou Qianhong Biopharma Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see Changzhou Qianhong Biopharma Co Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Changzhou Qianhong Biopharma Co Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Changzhou Qianhong Biopharma Co Ltd. See financial agility of Changzhou Qianhong Biopharma Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.83x | CN¥300.22 Million | CN¥361.36 Million | CN¥141.60 Million | ▲ +159.4% |
| 2024 | 0.32x | CN¥164.85 Million | CN¥514.71 Million | CN¥90.64 Million | ▼ -38.0% |
| 2023 | 0.52x | CN¥275.43 Million | CN¥533.33 Million | CN¥100.33 Million | ▼ -80.0% |
| 2021 | 2.58x | CN¥267.60 Million | CN¥103.56 Million | CN¥90.37 Million | ▲ +48.4% |
| 2020 | 1.74x | CN¥552.42 Million | CN¥317.28 Million | CN¥62.53 Million | ▼ -3.3% |
| 2019 | 1.80x | CN¥290.94 Million | CN¥161.55 Million | CN¥100.68 Million | ▼ -87.4% |
| 2018 | 14.28x | CN¥363.35 Million | CN¥25.45 Million | CN¥103.53 Million | ▲ +844.2% |
| 2017 | 1.51x | CN¥133.87 Million | CN¥88.52 Million | CN¥87.63 Million | ▲ +75.0% |
| 2016 | 0.86x | CN¥190.95 Million | CN¥221.01 Million | CN¥138.94 Million | ▼ -46.6% |
| 2015 | 1.62x | CN¥463.42 Million | CN¥286.50 Million | CN¥215.78 Million | ▲ +350.3% |
| 2014 | 0.36x | CN¥90.53 Million | CN¥252.01 Million | CN¥90.53 Million | ▼ -54.8% |
| 2013 | 0.80x | CN¥127.59 Million | CN¥160.47 Million | CN¥127.59 Million | ▲ +147.5% |
| 2012 | 0.32x | CN¥64.20 Million | CN¥199.82 Million | CN¥64.20 Million | ▲ +79.3% |
| 2011 | 0.18x | CN¥26.31 Million | CN¥146.82 Million | CN¥26.31 Million | ▲ +188.9% |
| 2010 | 0.06x | CN¥10.64 Million | CN¥171.51 Million | CN¥10.64 Million | ▼ -96.1% |
| 2009 | 1.60x | CN¥13.37 Million | CN¥8.35 Million | CN¥13.37 Million | ▲ +1075.1% |
| 2008 | 0.14x | CN¥7.41 Million | CN¥54.36 Million | CN¥7.41 Million | ▼ -29.6% |
| 2007 | 0.19x | CN¥6.97 Million | CN¥35.99 Million | CN¥6.97 Million | — |